ITK inhibitors (Vertex Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameITK inhibitors (Vertex Pharmaceuticals)
Drug Alias NameIL-2 inducible T-cell kinase inhibitors (Vertex Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsHypersensitivityAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVertex Pharmaceuticals Gmbh
Active IndicationsN/A
Inactive IndicationsHypersensitivityAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A